HYTN Innovations Announces the Resignations of Vic Neufeld and Dennis Staudt from the Board of Directors
VANCOUVER, British Columbia, April 11, 2023 - HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN), a Vancouver-based company specializing in the production of psychoactive and psychotropic compounds, announced today the immediate resignations of Vic Neufeld and Dennis Staudt from their positions as members of the Board of Directors (the "Board").
Vic Neufeld, a HYTN board member since its inception as a public company, has stepped down due to other commitments he is currently involved with. Mr. Neufeld expressed continued support for HYTN's vision and commended the passionate and dedicated team members who have propelled the company's expansion into new markets and geographies. Stating "I remain a steadfast supporter of HYTN's vision and extend my best wishes to the Board and management as they navigate the dynamic and challenging cannabis industry landscape."
Similarly, Dennis Staudt has also tendered his resignation from HYTN's Board of Directors. Mr. Staudt expressed appreciation for the opportunity to have served on the Board and conveyed confidence in the company's ability to overcome future challenges.
HYTN Innovations Inc. expresses gratitude to Mr. Neufeld and Mr. Staudt for their contributions and service on the Board of Directors and wishes them success in their future endeavors.
About HYTN Innovations Inc.
HYTN formulates, manufactures, markets, and sells premium products that contain psychoactive and psychotropic compounds. HYTN's mission is to become the top provider of these products in all federally regulated markets. To achieve this, the company focuses on identifying market opportunities and quickly bringing its innovative products to market through its elevated development platform.
For more information contact:
Elliot McKerr
Chief Executive Officer
1.866.590.9289
HYTN Investor Relations
1.866.590.9289
investments@hytn.life
The Canadian Securities Exchange (CSE) has not reviewed, approved, or disapproved the contents of this press release.
Certain information contained herein may constitute forward-looking statements that involve risks and uncertainties. Readers are cautioned not to place undue reliance on forward-looking statements, including, but not limited to, statements regarding: (i) the resignation of board members. Factors that could affect the Company's operations and performance include its ability to generate sufficient cash flow from operations; the Company's ability to access sources of debt and equity capital; competitive factors, pricing pressures and supply and demand in the Company’s industry; general economic and business conditions; and the effects and impacts of the COVID-19 pandemic, the extent and duration of which are uncertain at this time, on the Company's business and general economic and business conditions and markets. Any statements that are not statements of historical fact are deemed to be forward-looking statements. The forward-looking statements contained in this news release are made as of the date of this news release, and, except to the extent required by applicable law, the Company assumes no obligation to update or revise forward-looking statements made herein or otherwise, whether because of new information, future events, or otherwise. The forwardlooking statements contained in this news release are expressly qualified by this cautionary note.
